Seven NASDAQ Stocks on the Move February 23
Vivus (NASDAQ:VVUS) has traded as high as $21.44 during today’s trading session and last traded at $20.07 for a gain of 90.24% from yesterday’s close… VVUS shares have traded as high as $13.18 over the past 52 weeks, which is 52.27% off that high at last traded stock price. Get my next ALERT 100% FREE
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company’s lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators.
Onvia, Inc.(NASDAQ:ONVI) has traded as high as $4.29 during today’s trading session and last traded at $4.18 for a gain of 33.12% from yesterday’s close… ONVI shares have traded as high as $4.99 over the past 52 weeks, which is 16.23% off that high at last traded stock price.
For more than 12 years Onvia, the gBusiness Innovator, has been successfully delivering the research, analytics and tools companies rely on to succeed in gBusiness – the intersection of business and government and a $5.5 trillion market. Onvia tracks, analyzes and reports the spending of more than 89,000 federal, state and local government agencies, giving companies a single source for conducting open, intelligent and efficient business with government.
Charles & Colvard Ltd (NASDAQ:CTHR) has traded as high as $3.99 during today’s trading session and last traded at $3.89 for a gain of 27.54% from yesterday’s close… CTHR shares have traded as high as $3.99 over the past 52 weeks, which is 2.5% off that high at last traded stock price.
Charles & Colvard, Ltd., based in the Research Triangle Park area of North Carolina, is the global sole source of moissanite, a unique, near-colorless created gemstone that is distinct from other gemstones and jewels based on its exceptional fire, brilliance, luster, durability, and rarity. Charles & Colvard Created Moissanite® is currently incorporated into fine jewelry sold through domestic and international retailers and other sales channels.
Orexigen Therapeutics (NASDAQ:OREX) has traded as high as $3.98 during today’s trading session and last traded at $3.76 for a gain of 17.13% from yesterday’s close… OREX shares have traded as high as $3.52 over the past 52 weeks, which is 6.8% over that high at last traded stock price. Get my next ALERT 100% FREE
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave® has completed Phase 3 clinical trials for which a New Drug Application has been submitted and reviewed by the FDA, and the Company’s other product candidate, Empatic™, has completed Phase 2 clinical trials.
Discovery Laboratories (NASDAQ:DSCO) has traded as high as $3.40 during today’s trading session and last traded at $3.12 for a gain of 10.64% from yesterday’s close… DSCO shares have traded as high as $2.98 over the past 52 weeks, which is 4.7% over that high at last traded stock price.
Discovery Laboratories, Inc. is a specialty biotechnology company with one focus – to create life-saving products for critical care patients with respiratory disease and improve the standard of care for pulmonary medicine. Discovery Labs’ novel proprietary KL4 surfactant technology produces a synthetic, peptide- containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, lyophilized and aerosolized formulations.
CyberDefender Corporation (OTC:CYDE) has traded as low as $.08 during today’s trading session and last traded at $.09 for a loss of 48.14% from yesterday’s close… CYDE shares have traded as high as $2.50 over the past 52 weeks, which is 96.4% off that high at last traded stock price.
CyberDefender is a leading provider of remote technical support services, Internet security software and utilities directly to the consumer market. CyberDefender’s team of highly trained technicians and sales agents provide customers with efficient, round the clock remote PC repair services.
Microvision (NASDAQ:MVIS) has traded as low as $3.53 during today’s trading session and last traded at $3.58 for a loss of 8.21% from yesterday’s close… MVIS shares have traded as high as $13.76 over the past 52 weeks, which is 73.98% off that high at last traded stock price.
MicroVision provides the PicoP® display technology platform designed to enable next-generation display and imaging products for pico projectors, vehicle displays and wearable displays that interface with mobile devices. The company’s PicoP® laser display engine uses highly efficient laser light sources that create vivid images with high contrast and brightness.
More Posts by this author
Ten NASDAQ and NYSE Stocks on the Move February 24
America West Resources triples in Late Trading
Seven NASDAQ Stocks on the Move February 23
Seven NASDAQ and NYSE Stocks getting Attention, February 22
Five Penny Stocks on the Move on February 22
Seven Stocks under Four Bucks with Heavy Trading
Eight Stocks on the Move to watch for February 22
Post Written By: Oliver Crowne
Oliver Crowne is the main editor for http://www.StockPreacher.com |